Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer

SIMPLE SUMMARY: Pancreatic cancer is one of the deadliest solid malignancies. Pancreatic ductal adenocarcinoma accounts for 90% of pancreatic cancer cases with minimal response to traditional chemotherapies. Protein tyrosine kinases have been shown to be hyperactivated in cancers and thus can serve...

Descripción completa

Detalles Bibliográficos
Autores principales: Renuse, Santosh, Madamsetty, Vijay S., Mun, Dong-Gi, Madugundu, Anil K., Singh, Smrita, Udainiya, Savita, Mangalaparthi, Kiran K., Kim, Min-Sik, Liu, Ren, Kumar, S. Ram, Krasnoperov, Valery, Truty, Mark, Graham, Rondell P., Gill, Parkash S., Mukhopadhyay, Debabrata, Pandey, Akhilesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303779/
https://www.ncbi.nlm.nih.gov/pubmed/34298619
http://dx.doi.org/10.3390/cancers13143404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303779/
https://www.ncbi.nlm.nih.gov/pubmed/34298619
http://dx.doi.org/10.3390/cancers13143404

Ejemplares similares